As the lead advisor First National conducted a thorough due diligence of Medtech Diagnostics, developed the Sukuk structure and the legal framework for the issuance of Sukuk.

The Medtech Diagnostics Sukuk is issued under the concept of Musharakah Mutanaqisah (Diminishing Musharakah) at a profit sharing ratio of 95:5 (Investor:Managing Partner). The Sukuk is a MVR 30 million issuance with a tenure of 7 years.

This issuance marks the first ever private placement Sukuk issue through VIYANA of Maldives Stock Exchange.

We are extremely grateful for the Capital Market Development Authority, the market regulator, and the Maldives Stock Exchange team for the collaboration to make this a success.

It is indeed an important milestone for Medtech Diagnostics, a leading market player in the healthcare development sector in the Maldives, with a product portfolio renowned for high quality and reliability. We are grateful for the owners of Medtech Diagnostics for their trust in us and the team at Medtech Diagnostics for marking this a success.